Endoscopic Ultrasound Needles Market Share

North America Market Insights

North America is predicted to maintain its dominance in the global endoscopic ultrasound needles market during the discussed timeline, with a 40.9% share. High occurrence of gastrointestinal and pancreatic cancers, advanced healthcare infrastructure, and strong adoption of MIS technologies are collectively consolidating the region’s leadership in this sector. It also benefits from improved patient access to innovative medical devices, which is empowered by a streamlined and standardized regulatory framework. Besides, the extending Medicare coverage, incorporating EUS-based cancer diagnostics, is increasing procedural volumes across hospitals and specialized centers, reinforcing the significance of North America worldwide.

According to the NLM, 2.0 million new and 0.6 million death cases of cancer were registered across the U.S. in 2025 alone. In the same year, the American Cancer Society (ACS) unveiled that the number of cancer survivors in the country surpassed 18.6 million. These figures reflect the presence of a large consumer base and a favorable medical system, benefiting the endoscopic ultrasound needles market with greater adoption and cash inflow. The nation is also home to several global MedTech pioneers, making it an epicenter of growth for the region, while attracting more companies and investors to engage their resources in this landscape.

Canada is augmenting the endoscopic ultrasound needles market with the growing focus on elderly healthcare and minimally invasive technologies. As a result, major urban hospitals and cancer centers are increasingly investing in MIS-oriented infrastructural reinforcement, fueling the sector with stable capital influx. Moreover, national health policies and targeted R&D allocation to promote and enable equitable access to high-quality diagnostic care are cumulatively securing a prosperous future for this sector.       

APAC Market Insights

Asia Pacific is expected to attain the position of the fastest-growing region in the global endoscopic ultrasound needles market by the end of 2035. The region’s propagation in this sector is highly pledged to the amplifying burden of cancer mortality, rapid healthcare modernization, and massive government allocations in extensive research. Besides, the increasing awareness of minimally invasive diagnostic procedures among patients and medical service providers is also fueling demand in this category. Moreover, public efforts to expand accessibility towards rural areas are notably propelling the adoption rate in this sector.

China leads the Asia Pacific endoscopic ultrasound needles market on account of its large population, increasing incidence of gastrointestinal and pancreatic cancers, and rapid centralization of its healthcare system. Government support for healthcare reform, along with rising investments in advanced diagnostic technologies, is fueling the adoption of EUS procedures across the country. On the other hand, the growing presence of local and international medical device manufacturers and an expanding network of specialized hospitals are further accelerating progress in this landscape.

India is becoming a prominent contributor to the ongoing progress in the APAC endoscopic ultrasound needles market, fueled by the accelerating infrastructural development in healthcare. The rising occurrence of cancers and other associated ailments, coupled with the shifting preference to MIS procedures, is fostering a sustainable consumer base in the country. The lucrative environment of business for this category can also be testified by the substantial expansion of the MedTech industry in India, where the medical device industry is estimated to reach $30 billion by 2030, as per the PIB report.

Country-wise Count of Identified Cancer Cases (2022)

Source: NLM and Australian Government

Europe Market Insights

Europe is expected to remain a considerable contributor to the global endoscopic ultrasound needles market during the tenure between 2026 and 2035. The robust medical infrastructure, a high adoption rate of advanced clinical technologies, and a strong focus on early disease diagnosis are collectively solidifying the region's persistent growth in this sector. The amplifying patient volume of cancer, coupled with the growing geriatric population, is also creating a surge in less invasive diagnostic assessments, including EUS. Besides, supportive reimbursement policies, ongoing clinical research, and the presence of leading medical device companies are further contributing to the region's augmentation.

Germany attained leadership in the Europe endoscopic ultrasound needles market, which is accomplished through its wide network of advanced healthcare facilities, strong emphasis on clinical R&D, and the rapidly growing patient population demanding early-stage MIS-based detection services. The country’s increasing incidence of gastrointestinal and pancreatic diseases, along with a growing aging population, is fueling the need for effective diagnostic tools like EUS needles. This demography can be testified by the 2022 count of new cancer cases, accounting for 0.5 million, where the age-standardized incidence rate was 557 per 100 thousand citizens in Germany, as per the OECD findings.

The UK is progressing in the regional endoscopic ultrasound needles market with a continuous inflow of capital from the governing bodies. The growing focus on early cancer detection and increasing adoption of MIS techniques are attracting massive public and private investments toward this category. In addition, strong government backing through cancer screening programs, combined with ongoing advancements in healthcare technology and specialized medical training, is contributing to the steady expansion of the country in this field.